High Precision Optical One-to-One Cell Fusion
高精度光学一对一细胞融合
基本信息
- 批准号:7728353
- 负责人:
- 金额:$ 20万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-18 至 2011-09-17
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntibody FormationBiotechnologyCaliforniaCell CountCell LineCell NucleusCell SurvivalCell fusionCellsChemicalsChinese HamsterChinese Hamster Ovary CellCloningCollaborationsCulture MediaDevelopmentDimensionsDiseaseDyesEvaluationFeasibility StudiesFigs - dietaryGenerationsGenesGenetic MaterialsGerm CellsGoalsHybrid CellsHybridomasImageInternationalLabelLasersLeadLifeLightLiquid substanceMammalsMapsMeasuresMethodsMicrofluidicsMicroscopeMonitorMonoclonal AntibodiesMultiple MyelomaNitrogenNuclearOilsOperative Surgical ProceduresOpticsOvaryPatternPenicillinsPerforationPerformancePhasePhotonsPhysiologic pulsePolyethylene GlycolsPriceProcessPropertyProtein BiosynthesisProtocols documentationPyruvatePyruvatesReceptor CellResearch PersonnelSamplingScanningScientistShockSodiumSolutionsSorting - Cell MovementSourceSplenocyteSpottingsStaining methodStainsStem Cell ResearchStreptomycinSystemTechniquesTechnologyTestingTimeToxic effectTransfectionUltraviolet RaysUniversitiesVendoraqueousbasecancer immunotherapycell dimensioncell injurycell typecellular imagingcharge coupled device cameradesignelectric fieldfetal bovine serumfluorexonimprovedindexinginsightmonoclonal antibody productionnoveloptical trapsprototypepublic health relevanceresearch studysensorsuccesstoolvoltage
项目摘要
DESCRIPTION (provided by applicant): In the past decade, cell fusion has become a powerful tool for the analysis of hybridoma antibody production, cancer immunotherapy, gene transfection, chromosomal mapping, cloning mammals, and stem cell research. Until now, cell fusion techniques have been based on chemical and physical methods. Using these techniques, however, whole cell damage caused by some types of stimulation was unavoidable and a fusion of specific cells that are required for particular purposes was not possible because of the collective treatment. Therefore, Maxwell Sensors Inc. proposes to develop a novel Optical Cell Fusion (OC-Fusion) chip and system that combines the technologies of picodroplet and optical fusion to rapidly generate hundreds or thousands of hybrid cells with very high precision. The picodroplet method - rapidly and accurately pairs cells in contact with each other in a tiny droplet. A laser - precisely fuses a point at cell contact. The advantages of OC-Fusion are: 1. a versatile droplet technique rapidly pairs 1:1 selected cells in contact inside a picodroplet; the process does not depend on any natural cell contact, specific cell receptors, or labor-intensive optical trapping. 2. hundreds or thousands of hybrid cells can be generated with an image-assisted laser system used to scan the droplet array and precisely fuse the two cells at point contact (< 3<m) with a UV microbeam. In order to achieve the goal of the proposed project, the Phase I specific aims are to design and develop the OC-Fusion chip and system, characterize the system performance, develop protocol, perform and validate cell-cell electrofusion to fuse (1) cultured Chinese hamster ovary (CHO-k1) cells, and (2) splenocyte and myeloma. PUBLIC HEALTH RELEVANCE: Maxwell Sensors Inc. proposes to develop a compact single-cell fusing chip and system that enables to generate hundreds or thousands of fused cells for a variety of biotechnology and biomedical applications. Optical fusion, the process of using laser pulses to fuse two or more living cells, is a growing technology with a wide variety of applications. The technique is integral to cancer immunotherapy, monoclonal antibody generation and stem cell research where it affords researchers greater insight into how genes guide protein synthesis. The technique also allows researchers to create large quantities of different disease-specific antibodies and helps scientists clone mammals.
描述(由申请人提供):在过去的十年中,细胞融合已成为分析杂交瘤抗体产生,癌症免疫疗法,基因转染,染色体图,克隆哺乳动物和干细胞研究的强大工具。到目前为止,细胞融合技术一直基于化学和物理方法。但是,使用这些技术,不可避免地是由某些类型的刺激造成的全细胞损伤,并且由于集体治疗,无法为特定目的所需的特定细胞融合。因此,Maxwell Sensors Inc.提议开发一种新型的光细胞融合(OC融合)芯片和系统,该芯片和系统结合了Picodroplet和光学融合的技术,以迅速产生数百或数千种具有很高精度的混合细胞。 picodroplet方法 - 快速,准确地对彼此接触的细胞在微小的液滴中相互接触。激光 - 精确融合了细胞接触点。 OC融合的优点是:1。一种多功能的液滴技术迅速对1:1 picodroplet内的接触中选定的细胞配对;该过程不取决于任何自然细胞接触,特定的细胞受体或劳动密集型光学诱捕。 2。可以使用用于扫描液滴阵列的图像辅助激光系统生成数百或数千个杂种细胞,并在点接触(<3 <m)与紫外线微束精确融合两个细胞。为了实现拟议项目的目标,第一阶段的特定目的是设计和开发OC融合芯片和系统,表征系统性能,开发协议,执行和验证细胞细胞电渗fie(1)培养的中国中国仓鼠卵巢卵巢(CHO-K1)细胞(CHO-K1)细胞,以及(2)脾细胞和脊髓瘤。公共卫生相关性:Maxwell Sensors Inc.提议开发一种紧凑的单细胞融合芯片和系统,使能够为各种生物技术和生物医学应用生成数百或数千个融合细胞。光学融合是使用激光脉冲将两个或多个活细胞融合的过程,是一种具有多种应用的增长技术。该技术是癌症免疫疗法,单克隆抗体产生和干细胞研究不可或缺的,它使研究人员对基因如何指导蛋白质的合成有了更大的了解。该技术还允许研究人员创建大量不同疾病特异性抗体,并帮助科学家克隆哺乳动物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gao Chen其他文献
Gao Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gao Chen', 18)}}的其他基金
Single Cell Diagnosis of Leukemia using Multiplex Nested PCR System
使用多重巢式 PCR 系统单细胞诊断白血病
- 批准号:
7798761 - 财政年份:2010
- 资助金额:
$ 20万 - 项目类别:
Barcoded Magnetic Beads for Rapid Tests of MRSA and Respiratory Viral Panels
用于快速检测 MRSA 和呼吸道病毒检测的条形码磁珠
- 批准号:
7926790 - 财政年份:2010
- 资助金额:
$ 20万 - 项目类别:
Simultaneous Assay for Multiple Pathogens in Blood (SAMP-B)
血液中多种病原体的同时检测 (SAMP-B)
- 批准号:
8514698 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Simultaneous Assay for Multiple Pathogens in Blood (SAMP-B)
血液中多种病原体的同时检测 (SAMP-B)
- 批准号:
8315698 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Simultaneous Assay for Multiple Pathogens in Blood (SAMP-B)
血液中多种病原体的同时检测 (SAMP-B)
- 批准号:
7744078 - 财政年份:2009
- 资助金额:
$ 20万 - 项目类别:
Automated Tag Library Generation for Sequencing-Based Gene Expression Profiling
用于基于测序的基因表达谱的自动标签库生成
- 批准号:
7536140 - 财政年份:2008
- 资助金额:
$ 20万 - 项目类别:
Automated Tag Library Generation for Sequencing-Based Gene Expression Profiling
用于基于测序的基因表达谱的自动标签库生成
- 批准号:
7643949 - 财政年份:2008
- 资助金额:
$ 20万 - 项目类别:
Single Cell RNA Amplification Nanodrop Processor
单细胞 RNA 扩增 Nanodrop 处理器
- 批准号:
7928754 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
Single Cell RNA Amplification Nanodrop Processor
单细胞 RNA 扩增 Nanodrop 处理器
- 批准号:
7388346 - 财政年份:2007
- 资助金额:
$ 20万 - 项目类别:
A Parallel High-Throughput Pharmacogenetic Profiling Assay for Clinical Use
临床应用的并行高通量药物遗传学分析测定
- 批准号:
7617859 - 财政年份:2006
- 资助金额:
$ 20万 - 项目类别:
相似国自然基金
Tfh细胞调节自身抗体形成在溃疡性结肠炎体液免疫应答中的作用
- 批准号:81170361
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
胞内化抗体介导的HBcAg去功能化抑制HBV核壳体形成的机制研究
- 批准号:81070335
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
老年性和致病性II型胶原位点自身抗体形成机理探讨
- 批准号:39870857
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
用于完整表征抗体库的软件:从种系和 mRNA 序列组装到其蛋白质结构和靶标的深度学习预测
- 批准号:
10699546 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Tissue systems biology of immune dysregulation in aging by single cell spatial metabolomics
通过单细胞空间代谢组学研究衰老过程中免疫失调的组织系统生物学
- 批准号:
10647249 - 财政年份:2023
- 资助金额:
$ 20万 - 项目类别:
Development of nucleic acid-based vaccines against gonorrhea
开发基于核酸的淋病疫苗
- 批准号:
10539860 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Development of nucleic acid-based vaccines against gonorrhea
开发基于核酸的淋病疫苗
- 批准号:
10624940 - 财政年份:2022
- 资助金额:
$ 20万 - 项目类别:
Production of a Nanoparticle Vaccine to Aid in Smoking Cessation
生产有助于戒烟的纳米颗粒疫苗
- 批准号:
10194440 - 财政年份:2020
- 资助金额:
$ 20万 - 项目类别: